Health Ministry Invites Consortia of Medical Data-Centered Hospitals and AI SMEs

The Ministry of Health and Welfare and the Korea Health Information Service announced on March 30 that they will be accepting applications from consortia for the "2026 Medical AI Testbed Support Project" until May 4. The goal is to strengthen the competitiveness of the domestic medical artificial intelligence (AI) industry and to accelerate the digital transformation (AX) of the medical field.


Up to KRW 400 Million to Be Provided for "Medical AI Testbed Participant Institutions" View original image

This is the first year of the program, which has been established to support collaboration between small and medium-sized enterprises (SMEs) in the medical AI sector with advanced technological capabilities and medical data-centered hospitals with abundant clinical data.


Selected consortia will receive comprehensive support for building a pilot operation (testbed) environment to validate AI-based products and services in actual medical settings. This includes the design of evaluation indicators, integration of products and services, verification, and analysis of results.


While the introduction of medical AI products and services into the clinical field is expected to improve treatment outcomes and efficiency, it may also have unforeseen impacts on patients’ lives and health. Therefore, verification in real clinical environments is essential.


The Ministry of Health and Welfare stated, "This testbed support project is expected to provide a platform for collaborative validation between medical institutions and medical AI companies, and by verifying the clinical effectiveness and cost-effectiveness of medical AI products, it will facilitate their entry into the market and adoption by medical institutions, thereby contributing to the creation of an innovative medical AI growth ecosystem."


For Type 1, which targets AI digital medical devices licensed and approved by the Ministry of Food and Drug Safety and used directly in patient care, a total of KRW 3.2 billion will be provided to 12 projects. For Type 2, which targets AI solutions that are not medical devices but directly or indirectly improve the efficiency of the clinical process, a total of KRW 1.6 billion will be provided to 10 projects. Depending on the consortium's agreement and contract terms, up to KRW 400 million per project will be granted to cover the costs required for validation in real-world medical settings.



Medical institutions outside the Seoul metropolitan area will be given preferential consideration. Further details and application guidelines are available on the Healthcare Data Utilization Portal.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing